Company Filing History:

12 out of 870

Institut Pasteur

patents

9 out of 1,744

Institut National De La Sante Et De La Recherche Medicale

patents

1 out of 1

Institut Nationale De La Sante

Roche Molecular Systems, Inc.

patents

6. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2004

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6827933 - Immunogenic compositions of human papillomavirus and sera produced therefrom (2004-12-07),

2. 6391539 - Immunogenic compositions of human papillomavirus (2002-05-21),

3. 5981173 - Genital human papillomavirus type 68a (HPV-68a), related to the (1999-11-09),

4. 5968522 - Immunogenic compositions and antibodies directed against human (1999-10-19),

5. 5958674 - Probes for papillomaviruses and an in vitro diagnostic procedure for (1999-09-28),

6. 5876922 - Papillomavirus probe and a process for in vitro diagnosis of (1999-03-02),

7. 5824466 - Purified polypeptide of human papillomavirus type 49 (HPV49) type 50 (1998-10-20),

8. 5712092 - Papillomavirus probe and process for in vitro diagnosis of (1998-01-27),

9. 5665571 - Probes for papillomaviruses and an in vitro diagnostic procedure for (1997-09-09),

10. 5665535 - Polypeptides encoded by DNA sequences derived from the genome of the (1997-09-09),

11. 5656423 - DNA sequences derived from the genome of the papillomavirus HPV39, their (1997-08-12),

12. 5591574 - Probes, diagnostic method and immunization method based on (1997-01-07),

13. 5534439 - Isolated DNA of human papillomavirus type 55 (HPV55) (1996-07-09),

14. 5411857 - Probes for papillomaviruses and an in vitro diagnostic procedure for (1995-05-02),

15. 5342930 - Isolated DNA of human papillomavirus type 54(HPV54) (1994-08-30),

Title: The Innovative Contributions of Inventor Gerard Orth

Introduction: Gerard Orth, an accomplished inventor based in Sceaux, France, has made significant contributions to the field of medical science, particularly in the study and application of human papillomavirus (HPV). With 15 patents to his name, his work epitomizes innovation and dedication to advancing public health through groundbreaking research.

Latest Patents: Among Gerard Orth's most notable recent patents are those related to immunogenic compositions of human papillomavirus. His inventions include a purified human papillomavirus gene selected from the group consisting of E1, E6-E7, L1, and L2. These genes pertain to various strains of HPV, including HPV-2d, HPV-10b, HPV-14a, and others up to HPV-IP4. Additionally, he has developed immunogenic compositions of HPV DNA that leverage unique probes for detecting the virus. This work is vital in improving diagnostic methods and therapeutic strategies associated with HPV.

Career Highlights: Gerard has had a distinguished career with affiliations to renowned institutions in the field of microbiology and public health. Notably, he has contributed to the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale (INSERM), where his research has significantly advanced the understanding and management of viral infections.

Collaborations: Throughout his career, Gerard Orth has worked alongside prominent researchers, notably Dina Kremsdorf and Michel Favre. Their collaborations have fostered an environment of shared knowledge and innovation that has propelled their mutual research interests forward.

Conclusion: Gerard Orth stands as a prominent figure in the realm of medical innovation, specifically in the context of HPV research. His extensive patent portfolio and collaborations highlight his commitment to enhancing health outcomes through scientific discovery. As we continue to explore the complexities of human health, inventors like Gerard Orth play a crucial role in paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com